267 related articles for article (PubMed ID: 29942949)
1. Low molecular weight heparin-based reduction-sensitive nanoparticles for antitumor and anti-metastasis of orthotopic breast cancer.
Sun H; Cao D; Liu Y; Wang H; Ke X; Ci T
Biomater Sci; 2018 Jul; 6(8):2172-2188. PubMed ID: 29942949
[TBL] [Abstract][Full Text] [Related]
2. Development of low molecular weight heparin based nanoparticles for metastatic breast cancer therapy.
Sun H; Cao D; Wu H; Liu H; Ke X; Ci T
Int J Biol Macromol; 2018 Jun; 112():343-355. PubMed ID: 29409771
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy of doxorubicin, all-trans retinoic acid and low molecular weight heparin based on self-assembled multi-functional polymeric nanoparticles.
Zhang T; Xiong H; Dahmani FZ; Sun L; Li Y; Yao L; Zhou J; Yao J
Nanotechnology; 2015 Apr; 26(14):145101. PubMed ID: 25771790
[TBL] [Abstract][Full Text] [Related]
4. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
[TBL] [Abstract][Full Text] [Related]
5. Low molecular weight heparin modified bone targeting liposomes for orthotopic osteosarcoma and breast cancer bone metastatic tumors.
Wu H; Luo Y; Xu D; Ke X; Ci T
Int J Biol Macromol; 2020 Dec; 164():2583-2597. PubMed ID: 32795579
[TBL] [Abstract][Full Text] [Related]
6. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
Kumar P; Tambe P; Paknikar KM; Gajbhiye V
Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
[TBL] [Abstract][Full Text] [Related]
7. Polymer-Drug Nanoparticles Combine Doxorubicin Carrier and Heparin Bioactivity Functionalities for Primary and Metastatic Cancer Treatment.
Mei L; Liu Y; Xia C; Zhou Y; Zhang Z; He Q
Mol Pharm; 2017 Feb; 14(2):513-522. PubMed ID: 28026951
[TBL] [Abstract][Full Text] [Related]
8. Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice.
Zhang T; Prasad P; Cai P; He C; Shan D; Rauth AM; Wu XY
Acta Pharmacol Sin; 2017 Jun; 38(6):835-847. PubMed ID: 28216624
[TBL] [Abstract][Full Text] [Related]
9. Insight into the role of dual-ligand modification in low molecular weight heparin based nanocarrier for targeted delivery of doxorubicin.
Du H; Liu M; Yu A; Ji J; Zhai G
Int J Pharm; 2017 May; 523(1):427-438. PubMed ID: 28359815
[TBL] [Abstract][Full Text] [Related]
10. pH-activatable polymeric nanodrugs enhanced tumor chemo/antiangiogenic combination therapy through improving targeting drug release.
Xiong H; Wu Y; Jiang Z; Zhou J; Yang M; Yao J
J Colloid Interface Sci; 2019 Feb; 536():135-148. PubMed ID: 30366179
[TBL] [Abstract][Full Text] [Related]
11. A low-molecular-weight heparin-coated doxorubicin-liposome for the prevention of melanoma metastasis.
Chen Y; Peng J; Han M; Omar M; Hu D; Ke X; Lu N
J Drug Target; 2015 May; 23(4):335-46. PubMed ID: 25541466
[TBL] [Abstract][Full Text] [Related]
12. Anti-tumor drug delivery system based on cyclodextrin-containing pH-responsive star polymer: in vitro and in vivo evaluation.
Xiong Q; Zhang M; Zhang Z; Shen W; Liu L; Zhang Q
Int J Pharm; 2014 Oct; 474(1-2):232-40. PubMed ID: 25149124
[TBL] [Abstract][Full Text] [Related]
13. Antitumor and Antimetastasis Activities of Heparin-based Micelle Served As Both Carrier and Drug.
Mei L; Liu Y; Zhang H; Zhang Z; Gao H; He Q
ACS Appl Mater Interfaces; 2016 Apr; 8(15):9577-89. PubMed ID: 27058058
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-loaded polysaccharide nanoparticles suppress the growth of murine colorectal carcinoma and inhibit the metastasis of murine mammary carcinoma in rodent models.
Li M; Tang Z; Zhang D; Sun H; Liu H; Zhang Y; Zhang Y; Chen X
Biomaterials; 2015 May; 51():161-172. PubMed ID: 25771007
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of self-assembled nanoparticles based on low-molecular-weight heparin and stearylamine conjugates for controlled delivery of docetaxel.
Kim DH; Termsarasab U; Cho HJ; Yoon IS; Lee JY; Moon HT; Kim DD
Int J Nanomedicine; 2014; 9():5711-27. PubMed ID: 25525355
[TBL] [Abstract][Full Text] [Related]
16. Enhanced chemotherapeutic efficacy of the low-dose doxorubicin in breast cancer via nanoparticle delivery system crosslinked hyaluronic acid.
Wang Q; Zhong Y; Liu W; Wang Z; Gu L; Li X; Zheng J; Du H; Zhong Z; Xie F
Drug Deliv; 2019 Dec; 26(1):12-22. PubMed ID: 30691317
[TBL] [Abstract][Full Text] [Related]
17. Multi-stage inhibition in breast cancer metastasis by orally active triple conjugate, LHTD4 (low molecular weight heparin-taurocholate-tetrameric deoxycholate).
Alam F; Al-Hilal TA; Park J; Choi JU; Mahmud F; Jeong JH; Kim IS; Kim SY; Hwang SR; Byun Y
Biomaterials; 2016 Apr; 86():56-67. PubMed ID: 26890038
[TBL] [Abstract][Full Text] [Related]
18. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer.
Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J
Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin Hydrochloride-Loaded Mesoporous Silica Nanoparticles Inhibit Non-Small Cell Lung Cancer Metastasis by Suppressing VEGF-Mediated Angiogenesis.
Zhang M; Jiang L
J Biomed Nanotechnol; 2016 Nov; 12(11):1975-86. PubMed ID: 29363936
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional hybrid nanoconstructs facilitate intracellular localization of doxorubicin and genistein to enhance apoptotic and anti-angiogenic efficacy in breast adenocarcinoma.
Shukla RP; Dewangan J; Urandur S; Banala VT; Diwedi M; Sharma S; Agrawal S; Rath SK; Trivedi R; Mishra PR
Biomater Sci; 2020 Mar; 8(5):1298-1315. PubMed ID: 31903460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]